<?xml version="1.0" encoding="UTF-8"?>
<p>The opioid receptor-like 1 (ORL-1), recently named NOP, was identified in 1994 as a G-protein-coupled receptor that has a high degree of amino acid sequence homology to classic opioid receptors (δ, μ, and κ) [
 <xref rid="B85-molecules-26-00438" ref-type="bibr">85</xref>,
 <xref rid="B86-molecules-26-00438" ref-type="bibr">86</xref>,
 <xref rid="B87-molecules-26-00438" ref-type="bibr">87</xref>]. As an endogenous ligand of ORL-1, Nociceptin/orphanin (N/OFQ) is a peptide that initiates its function and is involved in pain regulation, cognition, anxiety and the cardiovascular system [
 <xref rid="B88-molecules-26-00438" ref-type="bibr">88</xref>,
 <xref rid="B89-molecules-26-00438" ref-type="bibr">89</xref>,
 <xref rid="B90-molecules-26-00438" ref-type="bibr">90</xref>,
 <xref rid="B91-molecules-26-00438" ref-type="bibr">91</xref>,
 <xref rid="B92-molecules-26-00438" ref-type="bibr">92</xref>,
 <xref rid="B93-molecules-26-00438" ref-type="bibr">93</xref>,
 <xref rid="B94-molecules-26-00438" ref-type="bibr">94</xref>].
</p>
